Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05584709
Title Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sorrento Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Columbia University Medical Center New York New York 10032 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field